Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cervical Cancer & Gynecologic Oncology

Krishnansu S. Tewari

克里希南苏·特瓦里

MD

🏢University of California, Irvine(加州大学欧文分校)🌐USA

Professor and Director, Division of Gynecologic Oncology妇科肿瘤学部主任、教授

62
h-index
2
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

Krishnansu S. Tewari, MD is a globally recognized leader in cervical cancer therapeutics at UC Irvine. He served as principal investigator of GOG0240, establishing bevacizumab plus chemotherapy as standard of care, and co-led KEYNOTE-826, incorporating pembrolizumab into first-line cervical cancer therapy, transforming outcomes for advanced disease.

Share:

🧪Research Fields 研究领域

Cervical Cancer宫颈癌
Pembrolizumab KEYNOTE-826帕博利珠单抗KEYNOTE-826
Bevacizumab GOG0240贝伐珠单抗GOG0240
Gynecologic Oncology Clinical Trials妇科肿瘤临床试验
Angiogenesis Inhibition血管生成抑制

🎓Key Contributions 主要贡献

GOG0240: Bevacizumab in Cervical Cancer

PI of GOG0240, the landmark phase III trial demonstrating that adding bevacizumab to chemotherapy significantly improved overall survival in recurrent/metastatic cervical cancer, leading to FDA approval and establishing anti-angiogenic therapy as standard of care.

KEYNOTE-826: Pembrolizumab in First-Line Cervical Cancer

Co-led KEYNOTE-826, the phase III trial showing pembrolizumab combined with chemotherapy ± bevacizumab significantly improved PFS and OS in persistent, recurrent, or metastatic cervical cancer, defining a new immunotherapy-based standard of care.

Representative Works 代表性著作

[1]

Bevacizumab Combined with Chemotherapy for Cervical Cancer

New England Journal of Medicine (2014)

GOG0240 results establishing bevacizumab plus chemotherapy as first targeted therapy to improve survival in advanced cervical cancer.

[2]

Pembrolizumab plus Chemotherapy in Cervical Cancer (KEYNOTE-826)

New England Journal of Medicine (2021)

Phase III trial demonstrating survival benefit of pembrolizumab added to first-line chemotherapy ± bevacizumab in advanced cervical cancer.

🏆Awards & Recognition 奖项与荣誉

🏆SGO Distinguished Service Award
🏆ASCO Stein Mentorship Award
🏆GOG/NRG Outstanding Investigator Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 克里希南苏·特瓦里 的研究动态

Follow Krishnansu S. Tewari's research updates

留下邮箱,当我们发布与 Krishnansu S. Tewari(University of California, Irvine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment